Jack L Wyszomierski Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months, 3 weeks ago
Jack L Wyszomierski has an estimated net worth of at least $15.7 million*, as of Oct. 29, 2025. They own 279,942 shares of EXEL stock. They have sold 157,083 shares of EXEL stock since 2021, for an estimated $1.5 million.
Jack L Wyszomierski $EXEL SEC Form 4 Insider Trading
Jack L Wyszomierski has filed a total of 7 insider trades in $EXEL since 2021. Their most recent trade was a sale of 99,574 shares, made on Feb 18, 2026. Their largest trade was a sale of 99,574 shares, made on Feb 18, 2026. We estimate that they now own 279,942 shares of $EXEL, worth an estimated $14.2 million.
Insider Trading at $EXEL
There have been a total of 128 insider trades reported at $EXEL since 2021, with 762,941 shares purchased and 4.0 million shares sold. The most active insider traders in $EXEL stock have been Patrick J. Haley, Jeffrey Hessekiel, and Dana Aftab. The most recent trade was a sale of 99,574 shares reported by JACK L WYSZOMIERSKI (None), made on Feb 18, 2026.
History of Insider Stock Trades by Jack L Wyszomierski
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
EXEL
|
Sale | 99,574 | Feb 18, 2026 | Feb. 20, 2026, 9:36 p.m. |
EXEL
|
Sale | 7,535 | Jun 03, 2025 | June 4, 2025, 7:57 p.m. |
EXEL
|
Sale | 8,768 | Feb 28, 2025 | Feb. 28, 2025, 9:34 p.m. |
EXEL
|
Sale | 8,287 | Jun 04, 2024 | June 6, 2024, 8:37 p.m. |
EXEL
|
Sale | 10,923 | May 13, 2024 | May 15, 2024, 7:44 p.m. |
EXEL
|
Sale | 15,300 | Mar 10, 2023 | March 14, 2023, 8:22 p.m. |
EXEL
|
Sale | 6,696 | Apr 04, 2022 | April 6, 2022, 8:08 p.m. |
$EXEL Executives and Stock Owners with Insider Trades
-
Patrick J. Haley, EVP, Commercial
-
Jeffrey Hessekiel, EVP, General Counsel & Sec
-
Dana Aftab, CSO/EVP Disc & Trans Research
-
Peter Lamb, EVP, Scientific Strategy & CSO
-
Christopher J. Senner, EVP and CFO
-
Jeffrey Hessekiel, EVP & General Counsel
-
Jeffrey Hessekiel, EVP and General Counsel
-
Amy C. Peterson, EVP Prod Dev & Med Aff & CMO
-
Brenda Hefti, SVP and General Counsel
-
Dana Aftab, EVP, Research and Development
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.